PI3-kinase is involved in mitogenic signaling by the oncogenic receptor tyrosine kinase Xiphophorus melanoma receptor kinase in fish melanoma

Experimental Cell Research

Volumn 251, Issue 2, 1999, Pages 340-349

  Wellbrock, Claudia ^a   Fischer, Petra ^a   Schartl, Manfred ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Melanoma; PI3 kinase; Receptor tyrosine kinase; Signal transduction; Xmrk

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; EPIDERMAL GROWTH FACTOR RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN TYROSINE KINASE; WORTMANNIN;

ANIMAL CELL; ARTICLE; AUTOPHOSPHORYLATION; CELL PROLIFERATION; CELL STRAIN BHK; CONTROLLED STUDY; ENZYME ACTIVITY; FISH; IN VITRO STUDY; MALIGNANT TRANSFORMATION; MELANOMA; MITOGENESIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RECEPTOR BINDING; SIGNAL TRANSDUCTION;

ANIMALIA; XIPHOPHORUS;

EID: 0033568180     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1999.4580     Document Type: Article

References (45)

1. Rodrigues G. A., Park M. Oncogenic activation of tyrosine kinases. Curr. Opin. Genet. Dev. 4:1994;15-24.
2. Schartl M. Platyfish and swordtail: A genetic system for the analysis of molecular mechanisms in tumor formation. Trends Genet. 11:1995;185-189.
3. Wittbrodt J., Adam D., Malitschek B., Mäueler W., Raulf F., Telling A., Robertson S. M., Schartl M. Novel putative receptor tyrosine kinase encoded by the melanoma-inducing Tu locus in Xiphophorus. Nature. 341:1989;415-421.
4. Ullrich A., Schlessinger J. Signal transduction by receptors with tyrosine kinase activity. Cell. 61:1990;203-212.
5. Wellbrock C., Fischer P., Schartl M. Receptor tyrosine kinase Xmrk mediates proliferation in Xiphophorus melanoma cells. Int. J. Cancer. 76:1998;437-442.
6. Winkler C., Wittbrodt J., Lammers R., Ullrich A., Schartl M. Ligand-dependent tumor induction in medakafish embryos by a Xmrk receptor tyrosine kinase transgene. Oncogene. 9:1994;1517-1525.
7. Wakamatsu Y. Establishment of a cell line from the platyfish-swordtail hybrid melanoma. Cancer Res. 41:1981;679-680.
8. Malitschek B., Wittbrodt J., Fischer P., Lammers R., Ullrich A., Schartl M. Autocrine stimulation of the Xmrk receptor tyrosine kinase in Xiphophorus melanoma cells and identification of a source for the ligand. J. Biol. Chem. 14:1994;10423-10430.
9. Wellbrock C., Lammers R., Ullrich A., Schartl M. Association between the melanoma-inducing receptor tyrosine kinase Xmrk and src family tyrosine kinases in Xiphophorus. Oncogene. 10:1995;2135-2143.
10. Wellbrock C., Geissinger E., Gómez A., Fischer P., Friedrich K., Schartl M. Signalling by the oncogenic receptor tyrosine kinase Xmrk leads to activation of STAT5 in Xiphophorus melanoma. Oncogene. 16:1998;3047-3056.
11. Wellbrock C., Schartl M. Multiple binding sites in the growth factor receptor Xmrk mediate binding to p59fyn, GRB2 and Shc. Eur. J. Biochem. 260:1999;275-283.
12. Wittbrodt J., Lammers R., Malitschek B., Ullrich A., Schartl M. The Xmrk receptor tyrosine kinase is activated in Xiphophorus malignant melanoma. EMBO J. 11:1992;4239-4246.
13. Whitman M., Downes C. P., Keeler M., Keller T., Cantley L. Type I phosphatidyinositol kinase makes a novel inositol phospholipid, phosphatidylinositol-3-phosphate. Nature. 332:1988;644-646.
14. Klippel A., Escobedo J. A., Fantl W. J., Williams L. T. The C-terminal SH2 domain of p85 accounts for the high affinity and specificity of the binding of phosphatidyinositol 3-kinase to phosphorylated platelet-derived growth factor β receptor. Mol. Cell. Biol. 12:1992;1451-1459.
15. Backer J. M., Myers M. G. Jr., Shoelson S. E., Chin D. J., Sun X. J., Miralpeix M., Hu P., Margolis B., Skolnik E. Y., Schlessinger J. Phosphatidylinositol 3′-kinase is activated by association with IRS-1 during insulin stimulation. EMBO J. 11:1992;3469-3479.
16. Fukui Y., Ihara S., Nagata S. Downstream of phophatidylinositol-3 kinase, a multifunctional signaling molecule, and its regulation in cell responses. J. Biochem. 124:1998;1-7.
17. Sugimoto Y., Whitman M., Cantley L. C., Erikson R. L. Evidence that the Rous sarcoma virus transforming gene product phosphorylates phosphatidylinositol and diacylglycerol. Proc. Natl. Acad. Sci. USA. 81:1984;2117-2121.
18. Exley M., Vartikovski L. Evidence for phosphatidylinositol 3-kinase-dependent T cell antigen receptor (TCR) signal transduction. Mol. Immunol. 34:1997;221-226.
19. Skouteris G. G., Georgakopoulos. Hepatocyte growth factor-induced proliferation of primary hepatocytes is mediated by activation of phosphatidylinositol 3-kinase. Biochem. Biophys. Res. Commun. 218:1996;229-233.
20. S6-kinase pathway induces B16 melanoma cell differentiation. J. Biol. Chem. 271:1996;31824-31830.
21. Fendly B. M., Winget M., Hudziak R. M., Lipari M. T., Napier M. A., Ullrich A. Characterization of murine monoclonal antibodies reactive to either the human epidermal growth factor receptor or HER2/neu gene product. Cancer Res. 50:1990;1550-1558.
22. Lax I., Bellot R., Howk R., Ullrich A., Givol D., Schlessinger J. Functional analysis of the ligand binding site of EGF receptor utilizing chimeric human/chicken receptor molecules. EMBO J. 8:1989;421-427.
23. Dhand R., Hiles I., Panayotou G., Roche S., Fry M. J., Gout I., Totty N. F., Truong O., Vicendo P., Yonezawa K., Kasuga M., Courtneidge S. A., Waterfield M. D. PI 3-kinase is a dual specificity enzyme: Autoregulation by an intrinsic protein-serine kinase activity. EMBO J. 13:1994;522-533.
24. Alessi D. R., Andjelkovic M., Caudwell B., Cron P., Morrice N., Cohen P., Hemmings B. A. Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J. 15:1996;6541-6551.
25. Mäueler W., Schartl A., Schartl M. Different expression patterns of oncogenes and proto-oncogenes in hereditary and carcinogen-induced tumors of Xiphophorus. Int. J. Cancer. 55:1993;288-296.
26. Vielkind U. Genetic control of cell differentiation in platyfish-swordtail melanomas. J. Exp. Zool. 196:1976;197-204.
27. Vlahos C. J., Matter W. F., Hui K. Y., Brown R. F. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J. Biol. Chem. 269:1994;5241-5248.
28. Valius M., Kazlauskas A. Phospholipase C-γ1 and phosphatidylinositol 3 kinase are the downstream mediators of the PDGF receptor′s mitogenic signal. Cell. 73:1993;321-334.
29. Prigent S. A., Gullick W. J. Identification of c-erbB-3 binding sites for phosphatidylinositol 3′-kinase and SHC using an EGF receptor/c-erbB-3 chimera. EMBO J. 13:1994;2831-2841.
30. Escobedo J. A., Kaplan D. R., Kavanaugh W. M., Turck C. W., Williams L. T. A phosphatidyinositol-3 kinase binds to platelet-derived growth factor receptors through a specific receptor sequence containing phosphotyrosine. Mol. Cell. Biol. 11:1991;1125-1132.
31. Bjorge J. D., Chan T-O., Antczak M., Kung H-J., Fujita D. J. Activated type I phosphatidylinositol kinase is associated with the epidermal growth factor (EGF) receptor following EGF stimulation. Proc. Natl. Acad. Sci. USA. 87:1990;3816-3820.
32. Hu P., Margolis B., Skolnik E. Y., Lammers R., Ullrich A., Schlessinger J. Interaction of phosphatidylinositol 3-kinase-associated p85 with epidermal growth factor and platelet-derived growth factor receptors. Mol. Cell. Biol. 12:1992;981-990.
33. Skolnik E. Y., Margolis B., Mohammadi M., Lowenstein E., Fischer R., Drepps A., Ullrich A., Schlessinger J. Cloning of PI3 kinase-associated p85 utilizing a novel method for expression/cloning af target proteins for receptor tyrosine kinases. Cell. 65:1991;83-90.
34. Songyang Z., Shoelson S. E., Chaudhuri M., Gish G., Pawson T., Haser W. G., King F., Roberts T., Ratnofsky S., Lechleider R. J., Neel B. G., Birge R. B., Fajardo J. E., Chou M. M., Hanafusa H., Schaffhausen B., Cantley L. C. SH2 domains recognize specific phosphopeptide sequences. Cell. 72:1993;767-778.
35. Soler C., Beguinot L., Carpenter G. Individual epidermal growth factor receptor autophosphorylation sites do not stringently define association motifs for several SH2-containing proteins. J. Biol. Chem. 269:1994;12320-12324.
36. Soltoff S. P., Carraway K. L. III, Prigent S. A., Gullick W. G., Cantley L. C. ErbB3 is involved in activation of phosphatidylinositol 3-kinase by epidermal growth factor. Mol. Cell. Biol. 14:1994;3550-3558.
37. Soltoff S. P., Cantley L. C. p120cbl is a cytosolic adaptor protein that associates with phosphoinisitide 3-kinase in response to epidermal growth factor in PC12 and other cells. J. Biol. Chem. 271:1996;563-567.
38. Moscatello D. K., Holgado-Madruga M., Emlet D. R., Montgomery R. B., Wong A. J. Constitutive activation of phosphatidylinositol 3-kinase by a naturally occurring mutant epidermal growth factor receptor. J. Biol. Chem. 273:1998;200-206.
39. Porter A. C., Vaillancourt R. R. Tyrosine kinase receptor-activated signal transduction pathways which lead to oncogenesis. Oncogene. 17:1998;1343-1352.
40. Jimenez C., Jones D. R., Rodriguez-Viciana P., Gonzalez-Garcia A., Leonardo E., Wennstrom S., von Kobbe C., Toran J. L., R-Borlado L., Calvo V., Copin S. G., Albar J. P., Gaspar M. L., Diez E., Marcos M. A., Downward J., Martinez A. C., Merida I., Carrera A. C. Identification and characterization of a new oncogene derived from the regulatory subunit of phosphoinositide 3-kinase. EMBO J. 17:1998;743-753.
41. Coffer P. J., Jin J., Woodgett J. R. Protein kinase B (c-Akt): A multifunctional mediator of phosphatidyl 3-kinase activation. Biochem. J. 335:1998;1-13.
42. Pullen N., Dennis P. B., Andjelkovic M., Dufner A., Kozma S. C., Hemmings B. A., Thomas G. Phosphorylation and activation of p70s6k by PDK1. Science. 279:1998;707-710.
43. Chung J., Kuo C. J., Crabtree G. R., Blenis J. Rapamycin-FKB specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinases. Cell. 69:1992;1227-1236.
44. Klingmüller U., Wu H., Hsiao J. G., Toker A., Duckworth B. C., Cantley L. C., Lodish H. F. Identification of a novel pathway important for proliferation and differentiation of primary erythroid progenitors. Proc. Natl. Acad. Sci. USA. 94:1997;3016-3021.
45. Sontag E., Sontag J. M., Garcia A. Protein phosphatase 2A is a critical regulator of protein kinase C zeta signaling targeted by SV40 small t to promote cell growth and NF-kappaB activation. EMBO J. 16:1997;5662-5671.